Microba Life Sciences Limited (ASX: MAP)
Health Care · Health Care Providers & Services · AU
AU$0.05
+4.08% today · -40.0% 1Y
Microba Life Sciences Limited (ASX: MAP) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $24.92M and employs 80 people.
Over the last twelve months the share price has lost 40.0%, trading between 0.04 and 0.11.
Tweenvest scores Microba Life Sciences Limited across four factors: quality 42/100, value 50/100, growth 100/100. Its strongest factor is growth.
MAP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $24.92M
- Revenue (TTM)
- $10.21M
- P/E
- —
- EPS
- -0.03
- Dividend yield
- —
- Beta (5Y)
- 2.10
- 52-week high
- AU$0.11
- 52-week low
- AU$0.04
- Avg volume (3M)
- —
- Shares outstanding
- 700.31M
- Employees
- 80
- Next earnings
- —
About Microba Life Sciences Limited
Microba Life Sciences Limited, established in Brisbane, Australia, in 2017, specializes in providing sophisticated microbiome testing and analytical services. These offerings reach clinicians, individual consumers, and research customers across key international markets, including Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, and the United States. The company delivers pathology, therapeutic, and diagnostic solutions deeply rooted in human gut microbiome science. Central to its operations is a comprehensive Databank, invaluable for unearthing therapeutic leads, fostering consumer health advancements, and identifying crucial diagnostic biomarkers. Moreover, Microba leverages a data-driven therapeutics platform to engineer innovative monoclonal microbial cell therapies aimed at treating inflammatory bowel disease, enhancing cancer immunotherapy, and managing autoimmune disorders.
- ISIN
- AU0000209868
- Founded
- 2017
- Listed since
- Apr 5, 2022
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| internet infinity Inc.TSE: 6545 | $26.03M | ¥771.00 | -0.52% |
| Third Age Health Services LimitedNZSE: TAH | $25.52M | NZ$4.57 | -3.99% |
| Cowealth Medical Holding Co., Ltd.TPEX: 4745 | $25.27M | NT$12.20 | +2.09% |
| Aashka Hospitals LimitedBSE: 543346 | $25.24M | Rs104.45 | -1.00% |
| Japan Hospice Holdings Inc.TSE: 7061 | $24.80M | ¥463.00 | -2.53% |
| PT Royal Prima TbkIDX: PRIM | $24.73M | Rp131.00 | +6.50% |
| Lotus Eye Hospital and Institute LimitedNSEI: LOTUSEYE | $24.48M | Rs113.93 | -1.51% |
| Pharmaceutical Centre S.A.CSE: VITAF | $24.33M | €— | — |
Figures last refreshed Oct 11, 2026.